Viking Therapeutics Stock Price - VKTX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 6.955 0.00 0.00 0.00 6.955 19:00:00
Bid Price Ask Price Spread Spread % News
6.97 7.07 0.10 1.41% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Viking Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 502.59M 72.26M $ -22.06M -0.40 - 69.48M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 2.00 3.90%

more financials information »

Viking Therapeutics News

Loading Messages....

Latest VKTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VKTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.447.506.937.081,353,136-0.485-6.52%
1 Month7.458.746.867.481,622,396-0.495-6.64%
3 Months7.398.746.157.101,356,927-0.435-5.89%
6 Months8.008.746.157.371,275,775-1.05-13.06%
1 Year9.9811.02946.158.262,060,831-3.03-30.31%
3 Years1.1424.000.889.561,744,9865.82510.09%
5 Years8.5024.000.889.141,196,920-1.55-18.18%

Viking Therapeutics Description

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.


Your Recent History
NASDAQ
VKTX
Viking The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.